0001144204-13-057627.txt : 20131202 0001144204-13-057627.hdr.sgml : 20131202 20131030134405 ACCESSION NUMBER: 0001144204-13-057627 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20131030 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VACCINOGEN INC CENTRAL INDEX KEY: 0001453001 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: MD FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 5300 WESTVIEW DRIVE STREET 2: SUITE 406 CITY: FREDERICK STATE: MD ZIP: 21703 BUSINESS PHONE: 301-668-8400 MAIL ADDRESS: STREET 1: 5300 WESTVIEW DRIVE STREET 2: SUITE 406 CITY: FREDERICK STATE: MD ZIP: 21703 CORRESP 1 filename1.htm

 

VACCINOGEN, INC.

5300 Westview Drive, Suite 406

Frederick, MD 21703

 

October 30, 2013

 

Jeffrey P. Riedler

Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549

 

Re:Vaccinogen, Inc.

Registration Statement on Form S-1

File No. 333-189927

 

Dear Mr. Riedler:

 

Vaccinogen, Inc. (the “Company”) hereby requests, pursuant to Rule 461 under the Securities Act of 1933, as amended, that the above-referenced registration statement be accelerated to 5:00 p.m., Eastern Time, on Thursday, October 31, 2013, or as soon thereafter as practicable.

 

The Company hereby acknowledges that:

 

1.should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;

 

2.the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

 

3.the Company may not assert staff comments or the declaration of effectiveness of this registration statement as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

 

 

Very truly yours,  
   
VACCINOGEN, INC.  
   
   
By: /s/ Michael G. Hanna, Jr., Ph.D.  
Michael G. Hanna, Jr. Ph.D.  
Chief Executive Officer